Hospital-acquired pneumonia due to Achromobacter xylosoxidans in the elderly: A single-center retrospective study in Beijing
Author(s) -
Chao Liu,
Jun Guo,
Weifeng Yan,
Yi Jin,
Fei Pan,
Xiangqun Fang,
Long Qin,
Changting Liu
Publication year - 2017
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.8747
Subject(s) - imipenem , medicine , achromobacter xylosoxidans , tazobactam , cefoperazone , pneumonia , sulbactam , levofloxacin , piperacillin , cilastatin , antibiotics , microbiology and biotechnology , pseudomonas aeruginosa , antibiotic resistance , genetics , bacteria , biology
Achromobacter xylosoxidans has been reported in several countries; however, hospital-acquired pneumonia (HAP) due to this organism in elderly patients in China remains rare.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom